|
Report Date : |
04.02.2013 |
IDENTIFICATION DETAILS
|
Name : |
WORLD PHARMA SERVICES S.A DE C.V. |
|
|
|
|
Registered Office : |
Prolongación Industria Textil 17, Col. Parque Industrial Naucalpan, 53489 Naucalpan de Juárez / Estado México |
|
|
|
|
Country : |
Mexico |
|
|
|
|
Date of Incorporation : |
25.09.2008 |
|
|
|
|
Legal Form : |
Stock Company of Variable Capital |
|
|
|
|
Line of Business : |
Specializes in connecting international manufacturers of active ingredients for drug development, with Mexican pharmaceutical companies interested. |
|
|
|
|
No. of Employees : |
14 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30th, 2012
|
Country Name |
Previous Rating (31.03.2011) |
Current Rating (30.06.2012) |
|
Mexico |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
MEXICO - ECONOMIC OVERVIEW
Mexico has a free market economy in the trillion dollar class. It contains a mixture of modern and outmoded industry and agriculture, increasingly dominated by the private sector. Recent administrations have expanded competition in seaports, railroads, telecommunications, electricity generation, natural gas distribution, and airports. Per capita income is roughly one-third that of the US; income distribution remains highly unequal. Since the implementation of the North American Free Trade Agreement (NAFTA) in 1994, Mexico's share of US imports has increased from 7% to 12%, and its share of Canadian imports has doubled to 5%. Mexico has free trade agreements with over 50 countries including Guatemala, Honduras, El Salvador, the European Free Trade Area, and Japan - putting more than 90% of trade under free trade agreements. In 2007, during its first year in office, the Felipe CALDERON administration was able to garner support from the opposition to successfully pass pension and fiscal reforms. The administration passed an energy reform measure in 2008 and another fiscal reform in 2009. Mexico''s GDP plunged 6.2% in 2009 as world demand for exports dropped, asset prices tumbled, and remittances and investment declined. GDP posted positive growth of 5.4% in 2010 and 3.8% in 2011, with exports - particularly to the United States - leading the way. The administration continues to face many economic challenges, including improving the public education system, upgrading infrastructure, modernizing labor laws, and fostering private investment in the energy sector. CALDERON has stated that his top economic priorities remain reducing poverty and creating jobs.
Source : CIA
IDENTIFICATION
|
|||||||||||||||||||
|
CORRECT COMPANY NAME |
WORLD PHARMA SERVICES
S.A DE C.V. |
||||||||||||||||||
|
TRADE NAME |
WORLD PHARMA
SERVICES |
||||||||||||||||||
|
TAXPAYER REGISTRATION |
RFC WPS0809251H1 |
||||||||||||||||||
|
MAIN ADDRESS |
Prolongación Industria Textil 17, Col.
Parque Industrial Naucalpan, |
||||||||||||||||||
|
POSTAL CODE |
53489 |
||||||||||||||||||
|
PROVINCE / DEPARTAMENT |
Naucalpan de Juárez / Estado México |
||||||||||||||||||
|
COUNTRY |
MEXICO |
||||||||||||||||||
|
TELEPHONE |
(5255) 55752948 |
||||||||||||||||||
|
E-MAIL |
amarquez@worldpharma.com.mx |
||||||||||||||||||
|
WEB |
www.worldpharma.com.mx |
||||||||||||||||||
|
COMMENTS |
We clarify that the correct tax registration number is shown above in the report.We further recall that the order came without phone number to expedite our investigation. |
||||||||||||||||||
|
|
|||||||||||||||||||
|
|||||||||||||||||||
|
|
|||||||||||||||||||
LEGAL BACKGROUNDS
|
|
|
LEGAL STATUS |
Stock Company of Variable Capital |
|
DATE OF INCORPORATION |
25SEP2008 |
|
PLACE OF REGISTRY |
Mexico D.F. |
|
DURATION |
99 years |
|
CURRENT PAID-IN CAPITAL |
Ps$810,000.= Pesos |
|
LAST CAPITAL INCREASE |
31/12/2011 (Last registered) |
|
CLASS OF SHARES |
Registered. |
|
CURRENT EXCHANGE RATE (US$) |
Ps$12.69 per 1.00 USADollar |
|
COMMENTS |
We were unable to obtain further registration details of this company, share capital nor more personal data of its members. |
DIRECTORS - EXECUTIVES –
SHAREHOLDERS
|
|||||||||||||||||
|
|
||||||||||||||||
WHO IS WHO?
|
|
|
BENITEZ
FERNANDEZ, JOAQUIN LUIS |
|
|
NATIONALITY |
Mexican |
|
D.O.B. |
02SEP1954 |
|
TAX ID |
BEFJ-540902-LXA |
|
BACKGROUND INFORMATION |
Studied at Staatliche Handelsschule "Am Lämmermarkt" (H2) Hamburg. |
|
|
|
|
NAIR, RAGESH |
|
|
NATIONALITY |
Indian |
BUSINESS HISTORY
|
|
World Pharma Services S.A. de C.V. is a 100% Mexican company which was founded on September 25, 2008 in Mexico City and currently specializes in connecting international manufacturers of active ingredients for drug development, with Mexican pharmaceutical companies interested.RELATED COMPANIES: The Subject is not related to any other company in the market. |
|
BUSINESS
|
|||||||||||||
|
SIC Classification |
|||||||||||||
|
Main activity |
World Pharma Services S.A. de C.V. is a company specializing in direct connection of international manufacturers of active ingredients for the development of drugs with pharmaceutical companies in Mexico to coordinate: price, payment times, delivery dates and in accordance with the quality and documentation required by their customers, in terms of: Granulometry Pharmacopoeial specifications Suitable packaging Documentation: Drug Master Files, Certificates of Good Manufacturing Practices (GMP's) International Licensing and Approvals, with particular emphasis on transparency as to the origins and manufacturers of active ingredients. In terms of current laws and regulations by the Cofepris, World Pharma Services S.A. de C.V. advises international manufacturers of active pharmaceutical ingredients on the most important regulatory issues to comply, in order that they promptly and expeditiously obtain Certificates of Good Manufacturing Practices (GMP'S Certificates) in accordance with existing legislation in Mexico. World Pharma Services S.A. de C.V. is one of the independent entities that has achieved the highest number of site visits to suppliers in India and China for the benefit of the Mexican pharmaceutical industry. |
||||||||||||
|
Import |
Yes |
||||||||||||
|
Country |
India, China and Switzerland |
||||||||||||
|
Export |
No |
||||||||||||
|
% Credit SALES / Terms |
100% (90-120 days) |
||||||||||||
|
% FOREIGN PURCHASES |
100% |
||||||||||||
|
SELLING TerritorY |
National market (100%) |
||||||||||||
|
EMPLOYEES |
14 |
||||||||||||
|
|||||||||||||
|
Comments |
According to customs on November 12, 2008 the RFC (Tax Registration) of the company, was recorded in the Register of Importers (Release No. 2142) under the Folio No. 321272.CLIENTS: The company sells to pharmaceutical, veterinary and food industry in general.
|
||||||||||||
FINANCIAL INFORMATION
|
||||||||||||
|
Interviewee(s) |
Ms. Sara Ponce |
|||||||||||
|
Position(s) |
Assistant Manager (Authorized) |
|||||||||||
|
Disposition |
POOR (Politely provided very few
information). |
|||||||||||
|
Information provided |
On management instructions, the interviewed person kindly provided general and operational data of the company and released the approximate turnover achieved during the year 2012. She said it would not be possible to reveal further financial data because she was not authorized.We have used other reliable sources to supplement information, it was virtually impossible to obtain complete balance sheets nor further reference figures by the said sources. |
|||||||||||
|
|
||||||||||||
|
|
||||||||||||
|
SALES |
US$ 10,000,000.00 (31DEC2012) |
|||||||||||
|
FINANCIAL SITUATION |
A-: SATISFACTORYAlthough we have no complete balances that allow us to determine Subject's actual condition, we point given its sales volume reached in 2012 coupled with good references given by its suppliers and absence of negative, that we conclude the subject is operating smoothly. |
|||||||||||
|
|
|
|
|
|
||||||||
|
INSURANCE |
||||||||||||
|
||||||||||||
|
TRADE REFERENCES, CREDIT BUREAU, LAWSUITS, BANKS (Confidential Information) |
||||||||||||||||||||||||||||||||||||||||||||||
|
TRADE REFERENCES |
||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||
|
Note : Other suppliers
did not provide information or could not be consulted |
|
|||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||
|
CREDIT HISTORY Earlier reports showed a clean trade record, no negative incidents. |
|
|||||||||||||||||||||||||||||||||||||||||||||
|
BANKERS The subject is a customer of those banks, which when consulted told us that in compliance with current legal regulations, can not provide data on their customer movements out of respect to banking secrecy. |
|
|||||||||||||||||||||||||||||||||||||||||||||
GENERAL INFORMATION
|
|
|
REPUTATION |
|
|
NOTHING AGAINST COMPANY |
|
|
|
|
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.53.32 |
|
|
1 |
Rs.84.60 |
|
Euro |
1 |
Rs.72.63 |
INFORMATION DETAILS
|
Report
Prepared by : |
PRL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors and their relative weights (as
indicated through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.